Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20624650 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Regulatory T-cells After Subcutaneous Immunotherapy
Conditions: Grass Pollen Allergy;   Specific Immunotherapy
2 Completed Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
Condition: Respiratory Hypersensitivity
Interventions: Biological: Acaroid;   Drug: Placebo

Indicates status has not been verified in more than two years